The Venture Codex

Led · Equity · Oct 2024

Kando provides a solution that leverages proprietary machine learning models trained on in-house IoT wastewater data to optimize wastewater quality management. The platform enables significant cost savings, enhances wastewater reuse, and supports sustainable urban water management in cities across the US and Europe. The company intends to use the new funds to drive global expansion, focusing on the US and Europe. Kando raised $10M in the latest round, bringing total capital raised to $30M. The company is based in Tel Aviv and was founded by Zohar Scheinin and Ari Goldfarb. Kando develops an end-to-end wastewater smart management solution combining hardware, cloud software and expert services to monitor key wastewater quality parameters in real time. Its core product is a cloud-based SaaS platform that tracks and reports wastewater collection-system metrics and supports big-data analytics. The company says it will use new funding for product and business development and to continue improving its monitoring and analytics tools. Kando was founded in 2011 by CEO Ari Goldfarb and employs a team of about 20 industry veterans across environmental, chemical and process engineering, project management and software development. The announcement does not disclose revenue or user metrics.

Participated · Equity · Feb 2022

XRHealth operates state-of-the-art therapeutic care Virtual Rooms built on proprietary FDA- and CE-registered medical extended reality (XR) technology. The platform integrates immersive XR technology, licensed clinicians, and advanced data analytics to provide remote rehabilitation, cognitive assessment and training, and pain management. XRHealth works with several U.S. healthcare providers, hospitals, and rehabilitation centers to deliver treatments in patients' homes. Led by CEO Eran Orr, the company was founded in 2016 and is headquartered in Boston, Massachusetts, with an R&D center in Tel-Aviv, Israel. The company plans to use the new funding to complete its merger with Amelia Virtual Care and to further develop an AI-based clinician to treat mental health conditions and guide physical and occupational therapy programs. XRHealth raised $6M in the reported funding round. XRHealth provides an FDA- and CE-registered extended reality (XR) platform that brings patient care into the Metaverse via therapeutic Virtual Rooms. The company combines proprietary medical virtual and augmented reality technology with licensed clinicians and advanced data analytics to deliver remote rehabilitation, cognitive assessment and pain-management solutions. XRHealth offers a variety of patent-pending therapeutic solutions spanning rehabilitation services, cognitive training and pain management. Following a $10M funding round, the company intends to use the proceeds to expand virtual healthcare treatment in the Metaverse. Founded in 2016 and led by CEO Eran Orr, XRHealth works with several U.S. healthcare providers, hospitals and rehabilitation centers. The company is based in Boston and maintains an R&D center in Tel-Aviv, Israel. XRHealth offers virtual treatment delivered by licensed clinicians using FDA-registered VR applications combined with data analytics. The company operates a virtual clinic that treats patients at home while they are remotely monitored by an XRHealth clinician. Its VR/AR platform includes real and virtual environments, games, and exercises addressing motor, cognitive, and physical symptoms across specialties such as physical, occupational and speech-language therapy, pain and ADHD management, memory/cognitive training, and post-COVID-19 rehabilitation. XRHealth is ISO certified, FDA registered and HIPAA compliant. The company intends to use the new funding to expand sales and marketing to bring VR/AR therapy to patients in the U.S., Australia and Israel. Led by Eran Orr, XRHealth is focused on scaling clinical deployment of its telehealth offerings. XRHealth is a VR telemedicine platform that offers FDA-registered software for remote treatment and rehabilitation. Its clinical applications include rehabilitation for back, shoulder and neck injuries, cognitive training and stress relief, and the company is courting developers to build additional therapeutic content. XRHealth also offers social features to run physician-moderated VR support groups and a web portal for medical professionals to track patient progress and challenges. The company rents hardware directly to consumers, ships Vive Focus and Pico Neo 2 headsets (and supports Oculus hardware), and during COVID-19 is waiving rental fees and working with insurers to waive co-pays. XRHealth said it expected to have more than 500 trained clinicians operating its software by the end of the month, indicating early clinician adoption. Financially, TechCrunch reports XRHealth raised $7 million in new funding, bringing total capital raised to $15 million, including a $4 million seed round in late 2018.

Participated · Series B · Feb 2022

Agritask is an open SaaS Agronomic Intelligence (AgI) platform that delivers actionable agronomic intelligence to the Food & Beverage industry and the wider agri-food ecosystem. Its platform monitors more than 50 crop types across over 2 million hectares in 35+ countries and is used in more than 30 countries. Customers include large-scale growers, multi-farm corporations, private equity, ag-buyers, food conglomerates, ag-financing and insurance companies, as well as governments and NGOs. Agritask is headquartered in Tel Aviv, employs 70 people worldwide and has offices in Brazil and Bulgaria. In February 2022 the company raised $26.0M in a Series B to accelerate product development, scale global sales and marketing, and attract and onboard key international talent. Agritask offers an agronomic management software platform that supports real-time decision-making across the full agricultural production process, from soil fertility management and growth monitoring to harvest logistics. The platform integrates with more than 40 hardware and software data sources, including John Deere, Airbus, IBM and SAP. It is active in 20 countries and covers over 50 crop types, and is used by farmers as well as food and beverage companies, agricultural insurers, input providers, and governments or developmental organizations. Customers include General Mills, Suzano and Bom Jesus. The company intends to use newly raised funds to enhance its data analytics features and to expand its customer reach, including projects serving smallholder farmers and the agricultural insurance sector. Founded in 2010 and led by CEO Ofir Ardon, Agritask targets scaled, data-driven farm management across multiple stakeholder groups.

Participated · Series A · Jan 2022

Addionics produces textured, three-dimensional copper and aluminum foil current collectors for lithium-ion batteries, using electro-deposition for copper and electroetching for aluminum. Its foils feature tiny holes and undulating peaks and valleys that increase contact between the foil and active material. The company says the design improves battery performance and efficiency and can potentially double battery lifespan, and that the collectors can work with a wide range of chemistries. Addionics plans to tailor collectors to different chemistries in the future to extract additional performance. The Israel- and U.K.-based startup recently raised a $39 million Series B to accelerate delivery of its current collectors and to explore new markets and geographies. Earlier this year it announced plans to build a $400 million factory in the U.S. and said it has letters of intent from U.S. automakers. Addionics develops patented Smart 3D Electrode architecture and a scalable electrode fabrication process that replaces traditional 2D layered electrodes, aiming to increase energy density, power, safety and lifetime without raising cost. Its drop-in solution is compatible with existing battery manufacturing lines and is paired with a proprietary AI algorithm to accelerate and optimize electrode design for varied applications. The company targets electric vehicles initially and is collaborating with automotive OEMs and suppliers in the U.S. and Europe to integrate with NMC, LFP, silicon, lithium polymer and solid-state chemistries. Addionics plans to commercialize by 2024 and will use funding to advance product development, expand the team, and increase activity in the U.S. and Germany. The company also highlights applications beyond EVs, including consumer electronics, stationary storage, aviation, defense and medical devices. Addionics has developed a scalable, patent‑protected “smart 3D structure” that redesigns battery architecture via 3D metal fabrication to reduce internal resistance and improve mechanical longevity and thermal stability. The company’s approach is chemistry‑agnostic, designed to enhance existing and future battery chemistries rather than replace them. Addionics says its technology can increase EV mileage, improve safety, and reduce cost and charging time, and could be applied to consumer electronics, medical devices, grid storage, drones, and more. Commercial traction is early: the company is working with an unnamed tier‑1 American automotive company on a proof‑of‑concept and testing Addionics cells in vehicles. Management aims to secure 3–4 major collaborations with world‑leading OEMs over the next year. Financially, the company has raised $6M in funding, which includes a $2.5M grant awarded through the European Union’s Horizon2020 program.

Led · Seed · Jul 2021

BioT offers a low-code, easy-to-integrate, cloud-based platform for medical device manufacturers that instantly connects patients with caregivers to support a seamless continuum of care. The product is a customizable, off-the-shelf solution built with security and regulatory liability considerations to lower barriers to connected care adoption. The company positions itself to help medical device makers convert traditional devices into connected solutions that reduce in-person follow-ups. BioT announced a $6.5 million Seed financing to support its growth. The capital will be used to expand the team, expedite development of the next generation of the platform, and support a growing sales pipeline in the US and Europe. The company also appointed Daniel Adler as its Chief Executive Officer.